Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.
Related Posts
Consumer sentiment reading rebounds to much higher level than expected as people get over tariff shock
The University of Michigan’s closely watched Surveys of Consumers showed across-the-board rebounds from previously dour readings.
Pope Francis remains hospitalized with pneumonia in both lungs, Vatican says
The pontiff has been recovering in a hospital in Rome after falling ill with a respiratory tract infection.
How Coach got its cool back
How Tapestry’s top brand Coach became cool again